16 January 2018
News and Views
Links and Services
A study in the latest issue of the Alimentary Pharmacology & Therapeutics evaluates the impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease.
The impact of early treatment with immunomodulators and/or TNF antagonists on bowel damage in Cro
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors